1
|
Hiepe F, Alexander T, Dörner T, Hauser AE, Hoyer BF, Kubagawa H, Skriner K, Tokoyoda K. [B lymphocytes and plasma cells as drivers of rheumatic diseases]. Z Rheumatol 2022; 81:660-666. [PMID: 35380249 PMCID: PMC8980791 DOI: 10.1007/s00393-022-01189-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/11/2022] [Indexed: 11/21/2022]
Abstract
Verschiedene Arbeitsgruppen am Deutschen Rheuma-Forschungszentrum Berlin haben in enger Zusammenarbeit mit der Medizinischen Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie an der Charité wichtige Beiträge zur Bedeutung der B‑Zellen und Plasmazellen bei rheumatischen Erkrankungen geleistet, die nicht nur für die Rheumatologie, sondern für alle klinischen Fachgebiete, in denen antikörpervermittelte Erkrankungen eine Rolle spielen, relevant sind. Insbesondere wird auf die gestörte B‑Zell-Homöostase, die Bedeutung des Immunglobulin M(IgM)-Fc-Rezeptors für die Regulation der Autoimmunität, die Rolle der langlebigen Gedächtnis-Plasmazelle bei der Aufrechterhaltung der Autoimmunität sowie die Sicherung ihres Überlebens in speziellen, von Stromazellen organisierten Nischen im Knochenmark und in entzündeten Geweben eingegangen. Die Forschungsergebnisse haben zu einem besseren Verständnis der immunologischen und molekularen Mechanismen bei rheumatischen Erkrankungen und ihrer Therapie beigetragen. Die Identifizierung der langlebigen Gedächtnis-Plasmazelle hat zu vielversprechenden therapeutischen Ansätzen mit kurativem Potenzial bei Autoimmunerkrankungen geführt.
Collapse
Affiliation(s)
- Falk Hiepe
- Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Berlin, Deutschland. .,Medizinische Klinik mit Schwerpunkt Rheumatologie u. Klinische Immunologie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and, Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Deutschland.
| | - Tobias Alexander
- Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Berlin, Deutschland.,Medizinische Klinik mit Schwerpunkt Rheumatologie u. Klinische Immunologie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and, Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Deutschland
| | - Thomas Dörner
- Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Berlin, Deutschland.,Medizinische Klinik mit Schwerpunkt Rheumatologie u. Klinische Immunologie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and, Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Deutschland
| | - Anja E Hauser
- Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Berlin, Deutschland.,Medizinische Klinik mit Schwerpunkt Rheumatologie u. Klinische Immunologie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and, Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Deutschland
| | - Bimba F Hoyer
- Klinik für Innere Medizin I, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Deutschland
| | - Hiromi Kubagawa
- Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Berlin, Deutschland
| | - Karl Skriner
- Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Berlin, Deutschland.,Medizinische Klinik mit Schwerpunkt Rheumatologie u. Klinische Immunologie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and, Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Deutschland
| | - Koji Tokoyoda
- Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Berlin, Deutschland
| |
Collapse
|
2
|
Chen Z, Wang JH. How the Signaling Crosstalk of B Cell Receptor (BCR) and Co-Receptors Regulates Antibody Class Switch Recombination: A New Perspective of Checkpoints of BCR Signaling. Front Immunol 2021; 12:663443. [PMID: 33841447 PMCID: PMC8027318 DOI: 10.3389/fimmu.2021.663443] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2021] [Accepted: 03/11/2021] [Indexed: 11/21/2022] Open
Abstract
Mature B cells express B cell antigen receptor (BCR), toll-like receptors (TLR) and TNF family receptors including CD40 and B-cell activating factor receptor (BAFFR). These receptors transduce cellular signals to govern the physiological and pathological processes in B cells including B cell development and differentiation, survival, proliferation, and antibody-mediated immune responses as well as autoimmune diseases and B cell lymphomagenesis. Effective antibody-mediated immune responses require class switch recombination (CSR), a somatic DNA recombination event occurring at the immunoglobulin heavy chain (Igh) gene locus. Mature B cells initially express IgM as their BCR, and CSR enables the B cells to switch from expressing IgM to expressing different classes of antibodies including IgG, IgA or IgE that exhibit distinct effector functions. Here, we briefly review recent findings about how the signaling crosstalk of the BCR with TLRs, CD40 and BAFFR regulates CSR, antibody-mediate immune responses, and B cell anergy.
Collapse
Affiliation(s)
- Zhangguo Chen
- Department of Immunology and Microbiology, University of Colorado, Aurora, CO, United States
| | - Jing H Wang
- Department of Medicine, Division of Hematology and Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
| |
Collapse
|
3
|
Dzangué-Tchoupou G, Allenbach Y, Preuße C, Stenzel W, Benveniste O. Mass cytometry reveals an impairment of B cell homeostasis in anti-synthetase syndrome. J Neuroimmunol 2019; 332:212-5. [PMID: 31082769 DOI: 10.1016/j.jneuroim.2019.04.014] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2018] [Revised: 03/25/2019] [Accepted: 04/25/2019] [Indexed: 01/03/2023]
Abstract
Recent data suggest the implication of T, B and NK cells in the anti-synthetase syndrome (ASyS); nevertheless their role and activation states are poorly described. We performed deep immune-profiling using 37 markers on peripheral blood cells from 10 ASyS patients versus 17 healthy donors (HD) and 26 myositis control patients. We show decreased percentages of memory B cells in ASyS patients (mean ± SEM: ASyS = 13 ± 3%, HD = 37 ± 4% and 'myositis controls' = 32 ± 3), counterbalanced by increased percentages of naïve B cells. Interestingly, perifascicular infiltrations of memory B cells within muscle biopsies of ASyS patients suggest that they niche within the muscle.
Collapse
|
4
|
Spielmann G, Agha N, Kunz H, Simpson RJ, Crucian B, Mehta S, Laughlin M, Campbell J. B cell homeostasis is maintained during long-duration spaceflight. J Appl Physiol (1985) 2018; 126:469-476. [PMID: 30496712 DOI: 10.1152/japplphysiol.00789.2018] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
Abstract
Long-duration spaceflights reportedly induce immune dysregulation, which is considered a risk to astronaut safety and mission success. Recent studies have examined the impact of spaceflight on markers of adaptive and innate immunity, but no study, to date, has comprehensively evaluated humoral immunity and serological markers of B cell function. The aim of this study was to characterize changes in B cell numbers and phenotypes, along with plasma Igs and polyclonal free light chains (FLCs)-near-"real-time" biomarkers of Ig synthesis-in response to an ~6-mo mission to the International Space Station (ISS). Whole-blood samples were collected before flight, during flight ("Early flight," "Mid-flight," and "Late flight"), immediately upon return, and during a recovery period (R + 18, R + 30/R + 33, and R + 60/R + 66) from 23 ISS crew members. B Cell counts and phenotypes were measured throughout the duration of the mission, along with total plasma Ig and FLC levels. There was no effect of spaceflight on the number and proportion of the different B cell subsets. There was no difference in kappa FLC between preflight samples and either in-flight or recovery samples ( P > 0.05), and only a marginal reduction was observed in lambda FLC levels upon return to Earth ( P < 0.05). Furthermore, IgG and IgM remained unchanged during and after spaceflight compared with preflight values ( P > 0.05). Of note, plasma IgA concentrations were elevated in-flight compared with baseline and recovery values ( P < 0.05). These results indicate that B cell homeostasis is maintained during long-duration spaceflight, advocating for potential in-flight vaccination as viable countermeasures against viral reactivation during exploration-class missions.
Collapse
Affiliation(s)
| | - Nadia Agha
- Laboratory of Integrated Physiology, Department of Health and Human Performance, University of Houston , Houston, Texas
| | - Hawley Kunz
- Laboratory of Integrated Physiology, Department of Health and Human Performance, University of Houston , Houston, Texas.,Division of Endocrinology and Metabolism, Mayo Clinic, College of Medicine , Rochester, Minnesota
| | - Richard J Simpson
- Laboratory of Integrated Physiology, Department of Health and Human Performance, University of Houston , Houston, Texas.,Department of Nutritional Sciences, The University of Arizona , Tucson, Arizona.,Department of Pediatrics, The University of Arizona , Tucson, Arizona.,Department of Immunobiology, The University of Arizona , Tucson, Arizona
| | - Brian Crucian
- National Aeronautics and Space Administration-Johnson Space Center , Houston, Texas
| | - Satish Mehta
- National Aeronautics and Space Administration-Johnson Space Center , Houston, Texas
| | - Mitzi Laughlin
- Laboratory of Integrated Physiology, Department of Health and Human Performance, University of Houston , Houston, Texas.,Fondren Orthopedic Group, Fondren Orthopedic Research Institute , Houston, Texas
| | - John Campbell
- School of Kinesiology, Louisiana State University , Baton Rouge, Louisiana.,Department for Health, University of Bath , Bath , United Kingdom
| |
Collapse
|
5
|
Chasset F, de Masson A, Le Buanec H, Xhaard A, de Fontbrune FS, Robin M, Rybojad M, Parquet N, Brignier AC, Coman T, Bengoufa D, Bergeron A, Peffault de Latour R, Bagot M, Bensussan A, Socié G, Bouaziz JD. APRIL levels are associated with disease activity in human chronic graft-versus-host disease. Haematologica 2016; 101:e312-5. [PMID: 26992945 DOI: 10.3324/haematol.2016.145409] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Affiliation(s)
- François Chasset
- INSERM and UMRS 976, Laboratory of Onco dermatology, Immunology, and Cutaneous Stem cells, F-75739 Paris University Paris Diderot, Sorbonne Paris Cité Dermatology Department, Saint-Louis Hospital, Paris
| | - Adèle de Masson
- INSERM and UMRS 976, Laboratory of Onco dermatology, Immunology, and Cutaneous Stem cells, F-75739 Paris University Paris Diderot, Sorbonne Paris Cité Dermatology Department, Saint-Louis Hospital, Paris
| | - Hélène Le Buanec
- INSERM and UMRS 976, Laboratory of Onco dermatology, Immunology, and Cutaneous Stem cells, F-75739 Paris University Paris Diderot, Sorbonne Paris Cité
| | - Aliénor Xhaard
- University Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris
| | - Flore Sicre de Fontbrune
- University Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris
| | - Marie Robin
- University Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris
| | - Michel Rybojad
- University Paris Diderot, Sorbonne Paris Cité Dermatology Department, Saint-Louis Hospital, Paris
| | - Nathalie Parquet
- University Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris Therapeutic Apheresis Unit, Saint-Louis Hospital, Paris
| | - Anne C Brignier
- University Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris Therapeutic Apheresis Unit, Saint-Louis Hospital, Paris
| | - Tereza Coman
- University Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris
| | - Djaouida Bengoufa
- University Paris Diderot, Sorbonne Paris Cité Immunobiology Department, Saint-Louis Hospital, Paris
| | - Anne Bergeron
- University Paris Diderot, Sorbonne Paris Cité Pneumology Department, Saint-Louis Hospital, Paris
| | - Régis Peffault de Latour
- University Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris
| | - Martine Bagot
- INSERM and UMRS 976, Laboratory of Onco dermatology, Immunology, and Cutaneous Stem cells, F-75739 Paris University Paris Diderot, Sorbonne Paris Cité Dermatology Department, Saint-Louis Hospital, Paris
| | - Armand Bensussan
- INSERM and UMRS 976, Laboratory of Onco dermatology, Immunology, and Cutaneous Stem cells, F-75739 Paris University Paris Diderot, Sorbonne Paris Cité
| | - Gérard Socié
- University Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris INSERM and UMRS1160, France
| | - Jean-David Bouaziz
- INSERM and UMRS 976, Laboratory of Onco dermatology, Immunology, and Cutaneous Stem cells, F-75739 Paris University Paris Diderot, Sorbonne Paris Cité Dermatology Department, Saint-Louis Hospital, Paris
| |
Collapse
|